Member Info for Adastra

The company indicated that the PFP Injectaclad division was working through initial projects for two major real-estate players and that Q4 was highly likely to give estate roll-outs as these completed. Given that Capex to expand is minimal that goes straight to the bottom line if all goes to plan. The other two divisions AgTech and CEM are also looking at increased work. A trading update has been issued in either Dec or Jan historically so anticipation will come into play I'm sure. Looks like a Happy Christmas and New Year for holders with major traction from the start of 2026.

Great British company in three active arenas. Motivated and invested management holding loads of shares. Seasoned and competent business strategy involving minimal Capex to expand. Solid.

Approaching the time of year when investors and pundits look towards share investments and recommendations for 2026...and... look no further. An hour's deep research here reveals a strong company with three active divisions in high growth 21st century fields. A highly motivated management with skin in the game and multiple near term inflection drivers to propel the MCap upwards. Primarily, the government is currently addressing the issue of flammable cladding on many buildings. It said that funding and the backlog would be cleared by the end of 2025. That leaves the door open for the Injectaclad division to work through it's big quoted workload. Highly cost effective, good margins and cheap for LST to scale. AgTech is progressing strongly and the CEM division should have good news from its recent engagement with the defence industry. Next t/u should confirm that progress. Solid company whose MCap should be in the £30m+ category given it's diversity and speciality exposure.

Should stimulate more informed decision making on investing here. It really is massively undervalued and should easily double (and more) given outlook. Solid.

Taken its time to rebound but everything is now in place for sustained rise to breach previous high. All drivers and fundamentals are sound. Perfect entry point for those prepared to do the research and make an informed investment decision.

Agree. Didn't think LST would be so under-the-radar that it dropped back to base level but that often happens with such tightly held shares on AIM. The upside is that virtually all stale holders will now have exited and we have a raft of new investors here at prices in excess of today. Fundamentals are all sound and in place with competent and seasoned (and deeply invested) management in place. Lots of potential news triggers to relight interest here and it's a superb target for 2026 investment comment in the run up to Christmas and New Year. I can see this easily doubling to a £30m MCap and above in 2026 given potential and quoted order pipeline. Injectaclad is the elephant in the room as urgency to rectify cladding issues intensifies and unlocks that side of the business book. AgTech has the ability to surprise and CEM has been courting the defence sector. Definitely not a share to be out of over the festive period. Got to be in it to benefit from the raft of RNS that could fall on the desk at any time. Given the regular and informative RNS stream, one looks imminent.

In answer to both your questions. Check my previous posts as I believe a positive t/u is due anytime. This is particularly relevant to Injectaclad as initial projects for two large real estate holders were due to be appraised and rolled out in this quarter. There are a small percentage (less than 1%) warrants still out there but pretty much at today's level. I do expect the next legup on the graph to happen soon as a result of next and subsequent RNS. Here is the current situation:

The two remaining live warrant tranches as at 31 March 2025 are:

1,000,000 warrants exercisable at £0.030 each, expiring 1 August 2028.

735,294 warrants exercisable at £0.042 each, expiring 10 December 2026.

Plus

Derivative classified warrants issued May 2025

£1.80 per share, expiring May 2028 — 250,000.

£1.80 per share, expiring June 2028 — 250,000

Par for the course - price will wobble as MMs juggle demand and supply. AIM just amplifies the effect. It can be frustrating for short-term holders who jump from loss to loss not realising that the amplification works much more as news is released. The upward trend and progress of the company is key which are both positive over the last year. Given the size and backlog of projects in all three divisions it is only a matter of time before the staircase moves again. The spike was the result of good news so expect more and a rising base level after each. If you've done the research here and the case for is vesting is still there ( or hugely increased at this level) then just hold tight. I expect a trading update within the next few weeks and the positivity in that could be fairly transformational if related to Injectaclad roll-outs or AgriTech major adoption.

On so many fundamentals this should easily double in 2026. Do the research and look at the interim statements:

PFP revenues in the Period grew significantly to £1.0m (H1 2024: £0.3m), with average gross margins increased to 64.3% (H1 2024: 41.2%). AGT revenues grew to £0.5m (H1 2024: £0.4m), with average gross margins of 42.0% (H1 2024: 48.4%) and CEM generated revenues of £3.6m (H1 2024: £4.5m). Importantly, CEM achieved gross margins of 27.8% (H1 2024: 23.7%), as the sales mix was more diverse and targeted. This resulted in an increased Group gross profit margin of 36.3% for the Period, up considerably from 26.6% in the first six months of 2024 and up from 30.3% for the 2024 full year.

Clearly CEM is the arm that was underperforming due to various factors. That is being fully addressed with multiple engagements focussed on the desire of UK industries to increasingly onshore, particularly in defence. Margins in the other two businesses are excellent so progress should be swift. Good time to board the train imo if not already invested and increasing.

Volume turnover is small. No declarations of change in holdings so par for the course really. I had expected the recent news items to support the increased MCap like yourself. Some fallback was essential to ensure the next upswing is stronger and sustained. The company has 3 constituent parts, all in must-have fields for future growth, and the seasoned and deeply invested management are quietly getting on with business. Each of the 3 arms could be next to RNS progress and a t/u is usually given in either Dec or Jan. If I had to guess, Injectaclad should be the first to herald a big increase in order conversion as the government ploughs money and effort into resolving the cladding issue. It is prioritising this in order to free up renting and mortgage bottlenecks and has said Dec or Jan should see very positive indications of movement. This should feed directly to LST bottom line. Also the engagement of CEM directly with defence companies in November should start to show progress. AgTech is also at the forefront as the northern hemisphere dark nights are here and food production increases come to the fore. All in all I'm confident this will resume it's upward trajectory. It's one of the few companies that are running into sustained profitability with a clear runway and isn't a one-trick pony. Solid British innovation that should be being rewarded with more onshore investors. Time the bigger instos took a look.

Last year's early December t/u should be repeated and conform strong trading progress. Perfect timing to raise the bar and the MCap. Didn't think I'd get a cheeky top up again at this level. Solid.

Apart from the numerous tower blocks held by investment companies, the Times reported last month that about 17,000 affordable house and flats are currently left unsold because housing associations can't afford to buy them as they have to spend so much on fixing cladding issues.

Bad for those who need housing. But good for LST supplying the cladding solutions. The government must task the Building Safety Regulator to unblock this huge backlog as fast as is possible. The solution is out there, just needs the processing of OKs to speed up.

With regard to the PFP division, Injecta Fire Barrier/Injectaclad. Thankfully, from all the latest data it looks like the Government Building Safety Regulator is getting to grips with the cladding issue backlog. The “speed up” is beginning to show, especially for new-build projects routed through the new Innovation Unit process. Hopefully end December or early January this should be communicated by the government. This should quickly start to free up the £28m quoted pipeline on LST PFP books.

Should get good t/u in next few weeks showing progress on all fronts. Super time for new investors to dyr and jump on board as LST has now consolidated. Stale holders, day traders and pre-Christmas cash outs have been replaced by existing long-termers and a raft of new investors who see the transformation here. Solid. Time to get a snapshot from the team that underpromises and overdelivers.

LST is the primary corporate mover for Injectaclad (they bought IFB and are the group promoting and scaling the solution).

Tragic incidents like this today only highlight the urgency to resolve flammable cladding issues in the UK and the massive cost-effectiveness and quick installation of LST Injectaclad.

At least four people have been killed in a major fire engulfing apartment blocks in Hong Kong

Woefully undervalued for all the reasons I've stated and restated here. Onward and upward......

Apologies the AgTech RNS was 27th Oct not Sept

All other details correct

On 12th Aug interims the 6/12 to March gave combined quoted orders for group of £58m

29th Sept RNS gave PFP division quoted pipeline of £28m

27th Sept RNS gave AgTech div. quoted pipeline of £45m

Thats £73m combined and CEM has also announced new contracts.

Agreed. When you invest in any stock it's the quality and depth of your research that influences you're decision. The underlying quality and commitment of the management team is fundamental. Are their aims aligned with all shareholders and do they hold a 'significant' shareholding in their own company. Are their goals aspirations and achievements being reflected in the company's progress. Are they organically growing and nurturing the businesses under their control whilst acquiring and assimilating good quality additions. Are the companies in high growth fields rather than mature or fading industries. Do they keep investors in touch with developments whilst not over-promising and under-delivering. Then stand back and think....has this got all the credentials to be a serious £100m turnover business in a sensible time frame?

If the answer is yes, then you're already invested here.

Job done. Just need patience now.